Acorda Therapeutics Inc logo

Acorda Therapeutics Inc

$ 0.61 -0.0159 (-2.54%) 10:08 PM EST
P/E:
At Loss
P/B:
0.20
Market Cap:
$ 14.88M
Enterprise V:
$ 187.94M
Volume:
137.06K
Avg Vol (2M):
5.54M
Also Trade In:
Volume:
137.06K
Market Cap $:
14.88M
PE Ratio:
At Loss
Avg Vol (2-Month):
5.54M
Enterprise Value $:
187.94M
PB Ratio:
0.20
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset 0.19
Debt-to-Equity 2.56
Debt-to-EBITDA -15.33
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.35
Distress
Grey
Safe
Beneish M-Score -3.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -41.2
3-Year Book Growth Rate -47.2
Name Current Vs Industry Vs History
5-Day RSI 42.97
9-Day RSI 46.97
14-Day RSI 49.58
6-1 Month Momentum % 115.96
12-1 Month Momentum % -72.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.71
Quick Ratio 1.34
Cash Ratio 0.49
Days Inventory 205.95
Days Sales Outstanding 42.09
Days Payable 135.3

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.8

Financials (Next Earnings Date:2023-03-04 Est.)

ACOR's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:ACOR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 124.063
EPS (TTM) ($) -6.93
Beta 2.03
Volatility % 284.26
14-Day RSI 49.58
14-Day ATR ($) 0.079679
20-Day SMA ($) 0.636215
12-1 Month Momentum % -72.41
52-Week Range ($) 0.2611 - 2.79
Shares Outstanding (Mil) 24.34

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acorda Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Acorda Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.